Related references
Note: Only part of the references are listed.Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies
S. Murray et al.
CANCER TREATMENT REVIEWS (2012)
Update of randomized trials in first-line treatment
M. A. Bookman
ANNALS OF ONCOLOGY (2011)
Peptides and Aptamers Targeting HSP70: A Novel Approach for Anticancer Chemotherapy
Anne-Laure Rerole et al.
CANCER RESEARCH (2011)
Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance
Thea Eline Hetland et al.
HUMAN PATHOLOGY (2011)
SUMO E3 ligase activity of TRIM proteins
Y. Chu et al.
ONCOGENE (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Increased Expression of Annexin A3 Is a Mechanism of Platinum Resistance in Ovarian Cancer
Xuedong Yan et al.
CANCER RESEARCH (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2
Rie Watanabe et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Characterization of the HDAC1 Complex That Regulates the Sensitivity of Cancer Cells to Oxidative Stress
Takuya Kato et al.
CANCER RESEARCH (2009)
Expression of Ret finger protein correlates with outcomes in endometrial cancer
Hirohisa Tsukamoto et al.
CANCER SCIENCE (2009)
Current status of gynecologic cancer in Japan
Kimio Ushijima
JOURNAL OF GYNECOLOGIC ONCOLOGY (2009)
Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome
Ahsan M. Kaimul et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Selective ablation of retinoblastoma protein function by the RET finger protein
M Krützfeldt et al.
MOLECULAR CELL (2005)
Anticancer agent CHS 828 suppresses nuclear factor-κB activity in cancer cells through downregulation of ikk activity
LS Olsen et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Mi-2β associates with BRG1 and RET finger protein at the distinct regions with transcriptional activating and repressing abilities
Y Shimono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Moderate progress for ovarian cancer in the last 20 years:: prolongation of survival, but no improvement in the cure rate
J Engel et al.
EUROPEAN JOURNAL OF CANCER (2002)
Part II: Chemotherapy for epithelial ovarian cancer - treatment of recurrent disease
M Harries et al.
LANCET ONCOLOGY (2002)
Vitamin D3-up-regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin
YL Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
RET finger protein is a transcriptional repressor and interacts with enhancer of polycomb that has dual transcriptional functions
Y Shimono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function
E Junn et al.
JOURNAL OF IMMUNOLOGY (2000)
Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: A gynecologic oncology group study
FM Muggia et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
